Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Apr
21
2020
Salvaging Patent Term Adjustment Under Supernus Foley & Lardner LLP
Apr
28
2020
Adjusting to Alice: USPTO’s View of Its Examination Guidelines Foley & Lardner LLP
Aug
18
2016
USPTO Sued Over December 2015 Holidays Foley & Lardner LLP
Oct
11
2016
Hillary Clinton's Intellectual Property Litigation Experience Foley & Lardner LLP
Oct
25
2016
Pharmaceutical Biogen TYSABRI Patents Spared Inter Partes Review Foley & Lardner LLP
Sep
29
2020
Federal Circuit Finds Agreement To Agree Not Enforceable Foley & Lardner LLP
Nov
30
2020
Federal Circuit Clarifies The “Reasonably Pertintent” Analogous Art Standard Foley & Lardner LLP
Apr
28
2017
2017 Mid-Year Statistics Point to Continued Rise in IPR Petitions Foley & Lardner LLP
May
22
2017
The Supreme Court Reverses Decades-Old Venue Precedent and Re-affirms Fourco Foley & Lardner LLP
Jun
5
2017
Conflict Between Granting a Preliminary Injunction and Staying the Case Pending Appeal of the Injunction Foley & Lardner LLP
May
25
2021
Sequence Listing Errors Can Rob You Of Patent Term Adjustment Foley & Lardner LLP
Feb
28
2015
FTC Fails to Prove Green Guides' Meaning of "Biodegradable" Foley & Lardner LLP
May
21
2015
Patent Safe Harbor Applies To Supplemental New Drug Applications Foley & Lardner LLP
Oct
3
2017
Federal Circuit Schools USPTO On Broadest Reasonable Claim Construction Foley & Lardner LLP
Jun
2
2015
Another Sequenom Patent Appeal Heads To The Federal Circuit Foley & Lardner LLP
May
31
2022
USPTO Open for Some In-Person Business Foley & Lardner LLP
Jul
19
2022
The Latest Patent Developments in China: What Manufacturers Need to Know Foley & Lardner LLP
Jul
21
2015
How Can You Safely Discuss Your IP with Others? Foley & Lardner LLP
Jul
28
2015
Bio/Pharma IPR Challenges Nearly Double In 2015 Foley & Lardner LLP
Feb
13
2018
When Does An RCE Stop The PTA Clock? Foley & Lardner LLP
Apr
25
2018
Supreme Court Holds That the PTO Cannot Institute Review on Only Some of the Challenged Claims Foley & Lardner LLP
May
22
2018
Patent Related Changes To Bayh-Dole Act Regulations Foley & Lardner LLP
Aug
7
2018
Sales Catalog From Dealer Trade Show Qualifies As Printed Publication Foley & Lardner LLP
Sep
18
2018
Federal Circuit Outlines Four Options For Overcoming Obviousness Rejections Based On Routine Optimization Foley & Lardner LLP
May
1
2023
Another Letter From Congress Complaining About Pharmaceutical Patents Foley & Lardner LLP
Oct
1
2018
Insurers Must Pay Cost of Defending Case Stemming from Use of Famous Marathoner’s Name Foley & Lardner LLP
May
16
2023
Supreme Court Won’t Hear Skinny Label Case Foley & Lardner LLP
Oct
26
2018
USPTO Announces Proposal To Facilitate Amendments In AIA Challenges Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins